In the article titled, “Synergistic Effect of MiR-146a Mimic and Cetuximab on Hepatocellular Carcinoma Cells” [1], the authors reported that they had misspelt the name of a cell line and supplied the incorrect figure for publication. The correct name of the cell line should be Hep3B, instead of HepB3. The correct Figure 8 is displayed below. The results and conclusions described therein are not affected by these corrections.
Special Issue
Corrigendum | Open AccessHepatocellular Carcinoma: Carcinogenesis, Establishment, Progression, and Therapies
View this Special IssueCorrigendum to “Synergistic Effect of MiR-146a Mimic and Cetuximab on Hepatocellular Carcinoma Cells”
Received30 Nov 2020
Accepted30 Nov 2020
Published21 Dec 2020
References
S. Huang, R. He, M. Rong, Y. Dang, and G. Chen, “Synergistic effect of miR-146a mimic and cetuximab on hepatocellular carcinoma cells,” BioMed Research International, vol. 2014, Article ID 384121, 15 pages, 2014.
View at: Publisher Site | Google Scholar
Copyright
Copyright © 2020 Suning Huang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.